Tag: IPIX

Sticking with SPY Puts

Solid Hits on the SPY

We try to formulate new options ideas for a given session as often as we can without forcing the issue, and on most days we produce at least one. Yesterday, we designated our sole set of new contracts to watch as the SPY Weekly $250-248 Puts, and thanks to a painful day for the markets, we were afforded the chance to score some pretty nice intraday gains.

Two out of three of those strike points translated into instant double-bag opportunities, with the third falling just 1% short of that mark, providing the following moves on the day: 

SPY Weekly $250-248 Puts
$250: 4.39-8.73 (+99%)
$249: 4.00-8.10 (+103%)
$248: 3.65-7.50 (+105%)
______

Fresh Ideas:
SPY Weekly $244-242 Puts
WBA Weekly $44-45 Calls
KMX Weekly $50-55 Calls


CytoDyn, Inc. CYDY

We began tracking CYDY on Tuesday morning, and in addition to making a nominal move on the chart, the company has also put out some coronavirus related press in the couple days. One of the company’s investigational drugs which is about to enter Phase 2b/3 trials, has demonstrated a promising level of  efficacy among severe COVID-19 patients.

The stock itself has run from 2.65-3.09 in the past couple of sessions, which marks a move of just 17% but we’re going to be interested to continue tracking its performance in light of the company’s announcements.

VANCOUVER, Washington, April 02, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the three-day effect of leronlimab in eight severely ill COVID-19 patients demonstrated a significant improvement in several important immunologic bio-markers.  Patient test data reveals improvement in cytokines, IL-6, and a trend toward the normalization of the CD4/CD8 ratio. (>>View Full PR)


Extended Watchlist:
GRYO, PNAT, ROTH, SOLI, CTYX, IPIX

Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%

Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:

CPB, APRN, CLX, GIS, PG

Extended Watchlist:
MATN, ZOOM, DECN, PCTL, NBDR, IPIX, GNPX, GNBT

Market Volatility Spikes, Creating Opportunity

Inovio Pharmaceuticals INO

It appears the markets are once again getting absolutely hammered this morning, and we are back to focusing on those plays which have been enjoying success amid the coronavirus outbreak.  INO is chief among them, largely due to the fact that the company plans to begin human testing of a coronavirus vaccine starting next month.

We tagged this stock for observation back on February 27th, and it has continued to set new highs for us all along the way. From our low of 3.83 INO has now reached 16.00, which works out to total increase of 318%

SPDR S&P500 (ETF) SPY – Recap

We also put forth some SPY Calls in Friday morning’s report, the SPY Weekly $294-295.50 Calls and those produced massive gains in a late day surge, ranging from 900-1100% The market volatility that scares most people, gives short term opportunistic traders like ourselves dollar signs in our eyes, and we’ve been coming up big throughout this very tenuous situation.  .

Weekly $294-295.50 Calls
$294: .46-4.70 (+921%)
$295: .30-3.70 (+1133%)
$295.50: .24-3.05 (+1171%)

OTC Watchlist

When big boards get crushed, the OTC becomes something of a haven for traders who are looking for some action during this tumultuous time Here we have a watchlist of some of the ones we’ve been tracking, as well as some new targets to watch.

AGTK, FZRO, IPIX, GRPS, RAFA, NVNT, NUGL, PHOT